Pemetrexed for Injection, USP

Pemetrexed for injection, USP, is a chemotherapy medication used in the treatment of certain types of cancer, particularly non-small cell lung cancer (NSCLC) and mesothelioma.

It is categorized as an antifolate antineoplastic agent and works by inhibiting certain enzymes involved in DNA and RNA synthesis, ultimately preventing the growth and spread of cancer cells.

Pemetrexed is typically administered intravenously (IV) by healthcare professionals in a clinical setting. The dosage and treatment regimen are determined by a healthcare provider based on various factors, including the type and stage of cancer, the individual’s overall health, and other treatments being used.